Clinical Trials Search
Smartphone-Based Assessment of Patient-Reported Outcomes Related to Receipt of Immunotherapy
The purpose of this study is to better understand the side effects that cancer patients experience while they are taking immunotherapy such as pembrolizumab, nivolumab, atezolizumab, or ipilimumab. Investigators hope to use this information to help better educate future patients who are taking immunotherapy, on what to expect and how to feel their best.
To understand patients, caregivers, and oncologists perspectives about irAEs through qualitative data collection. To quantitatively characterize the frequency, severity, and longitudinal course of patient-reported irAEs and changes in quality of life secondary to receipt of an immune checkpoint inhibitor.